First Trust Mid Cap Core AlphaDEX Fund (FNX)

The First Trust Mid Cap Core AlphaDEX Fund presents a classic case of a solid, undervalued compounder currently weighed down by recent technical weakness. Fundamentally, the business is on a superior trajectory, having delivered a +131% cumulative return over the last nine years with seven out of nine years showing positive growth. Crucially, the most recent annual performance was up (+5%), meaning the multi-year decline penalty does not apply; the market has not yet punished the company for structural deterioration. At a trailing P/E of roughly 14, the valuation is attractive relative to its historical growth profile. However, the short-term outlook is clouded by momentum. The stock is trading significantly below its 50-day and 200-day moving averages, indicating that recent price action has been bearish. While the statistical forecast model offers a slight positive lean, it is too weak to overcome the visible technical resistance. The dividend yield of 1.03% provides a modest floor but is insufficient to drive a standalone income strategy. For investors, this is a 'buy on weakness' scenario where the long-term thesis remains intact despite the short-term headwinds.